Siga amends international promotion agreement with meridian to enhance international growth opportunities of oral tpoxx®

New york, april 01, 2024 (globe newswire) -- siga technologies, inc. (nasdaq: siga), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that it entered into an amendment to its international promotion agreement with meridian medical technologies, inc. (meridian). effective june 1, siga will drive international promotion activities for oral tpoxx® while maintaining its contractual relationship with meridian to maintain continuity for key customer relationships.
SIGA Ratings Summary
SIGA Quant Ranking